About the Hematological Oncology Session
Hematological oncology, a field devoted to blood cancers, encompasses research aimed at understanding, diagnosing, and treating malignancies like leukemia, lymphoma, and myeloma. Cutting-edge studies focus on elucidating the genetic and molecular mechanisms driving these diseases, leading to targeted therapies that offer improved outcomes and reduced side effects compared to traditional treatments. Advanced diagnostic techniques, such as next-generation sequencing and liquid biopsies, enable earlier detection and monitoring of disease progression. Additionally, immunotherapies, including CAR-T cell therapy, are revolutionizing treatment paradigms by harnessing the body's immune system to specifically target cancer cells. Collaborative efforts between researchers, clinicians, and pharmaceutical companies continue to drive innovation in hematological oncology, offering hope for better prognoses and enhanced quality of life for patients battling these complex diseases.
Topics Covered in Hematological Oncology
Acute Leukemias
Lymphoma Subtypes
Multiple Myeloma
Myelodysplastic Syndromes
Flow Cytometry
Bone Marrow Transplant
Related Scientific Sessions at CIOC 2027
Why Attend the Hematological Oncology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Hematological Oncology work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Hematological Oncology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Hematological Oncology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Hematological Oncology Conference 2027 — FAQs
What is the Hematological Oncology track at CIOC 2027?
The Hematological Oncology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Hematological Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Hematological Oncology sessions?
Cancer researchers and clinicians, educators and students with an interest in Hematological Oncology are all welcome — whether presenting or attending.
Can I present my research in the Hematological Oncology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Hematological Oncology sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Hematological Oncology track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.